Importance of monitoring arsenic methylation metabolism in acute promyelocytic leukemia patients receiving the treatment of arsenic trioxide
- Location
-
Deutsche Nationalbibliothek Frankfurt am Main
- ISSN
-
2162-3619
- Extent
-
Online-Ressource
- Language
-
Englisch
- Notes
-
online resource.
- Bibliographic citation
-
Importance of monitoring arsenic methylation metabolism in acute promyelocytic leukemia patients receiving the treatment of arsenic trioxide ; volume:10 ; number:1 ; day:6 ; month:2 ; year:2021 ; pages:1-10 ; date:12.2021
Experimental hematology & oncology ; 10, Heft 1 (6.2.2021), 1-10, 12.2021
- Creator
-
Zheng, Yu
Mao, Yuan-Fei
Zhao, Hui-Jin
Chen, Li
Wang, Li-Ning
Zhang, Yun-Xiang
Hu, Jiong
Li, Jun-Min
Li, Xiao-Yang
Zhu, Hong-Ming
- Contributor
-
SpringerLink (Online service)
- DOI
-
10.1186/s40164-021-00205-6
- URN
-
urn:nbn:de:101:1-2021032918435107576241
- Rights
-
Open Access; Der Zugriff auf das Objekt ist unbeschränkt möglich.
- Last update
-
14.08.2025, 10:54 AM CEST
Data provider
This object is provided by:
Deutsche Nationalbibliothek. If you have any questions about the object, please contact the data provider.
Deutsche Nationalbibliothek. If you have any questions about the object, please contact the data provider.
Associated
- Zheng, Yu
- Mao, Yuan-Fei
- Zhao, Hui-Jin
- Chen, Li
- Wang, Li-Ning
- Zhang, Yun-Xiang
- Hu, Jiong
- Li, Jun-Min
- Li, Xiao-Yang
- Zhu, Hong-Ming
- SpringerLink (Online service)
Other Objects (12)
The third way of inclusive growth in China
ATO (Arsenic Trioxide) effects on promyelocytic leukemia nuclear bodies reveals antiviral intervention capacity
Arsenic trioxide promoting ETosis in acute promyelocytic leukemia through mTOR-regulated autophagy
ATO (Arsenic Trioxide) Effects on Promyelocytic Leukemia Nuclear Bodies Reveals Antiviral Intervention Capacity
Untersuchung der Osteokonduktion verschiedener Knochenersatzstoffe
Clinical Indicators of Hepatotoxicity in Newly Diagnosed Acute Promyelocytic Leukemia Patients Undergoing Arsenic Trioxide Treatment
Relapsed acute promyelocytic leukemia in a hemodialysis-dependent patient treated with arsenic trioxide: a case report
A model of tournament incentives with corruption
Speciation of arsenic trioxide metabolites in peripheral blood and bone marrow from an acute promyelocytic leukemia patient
A drug from poison: how the therapeutic effect of arsenic trioxide on acute promyelocytic leukemia was discovered
PML-RARA mutations confer varying arsenic trioxide resistance
Fertility and parenthood in patients with acute promyelocytic leukemia treated with Arsenic Trioxide and All-Trans retinoic acid
The third way of inclusive growth in China
ATO (Arsenic Trioxide) effects on promyelocytic leukemia nuclear bodies reveals antiviral intervention capacity
Arsenic trioxide promoting ETosis in acute promyelocytic leukemia through mTOR-regulated autophagy
ATO (Arsenic Trioxide) Effects on Promyelocytic Leukemia Nuclear Bodies Reveals Antiviral Intervention Capacity
Untersuchung der Osteokonduktion verschiedener Knochenersatzstoffe
Clinical Indicators of Hepatotoxicity in Newly Diagnosed Acute Promyelocytic Leukemia Patients Undergoing Arsenic Trioxide Treatment
Relapsed acute promyelocytic leukemia in a hemodialysis-dependent patient treated with arsenic trioxide: a case report
A model of tournament incentives with corruption
Speciation of arsenic trioxide metabolites in peripheral blood and bone marrow from an acute promyelocytic leukemia patient
A drug from poison: how the therapeutic effect of arsenic trioxide on acute promyelocytic leukemia was discovered
PML-RARA mutations confer varying arsenic trioxide resistance
Fertility and parenthood in patients with acute promyelocytic leukemia treated with Arsenic Trioxide and All-Trans retinoic acid
The third way of inclusive growth in China
ATO (Arsenic Trioxide) effects on promyelocytic leukemia nuclear bodies reveals antiviral intervention capacity
Arsenic trioxide promoting ETosis in acute promyelocytic leukemia through mTOR-regulated autophagy
ATO (Arsenic Trioxide) Effects on Promyelocytic Leukemia Nuclear Bodies Reveals Antiviral Intervention Capacity
Untersuchung der Osteokonduktion verschiedener Knochenersatzstoffe
Clinical Indicators of Hepatotoxicity in Newly Diagnosed Acute Promyelocytic Leukemia Patients Undergoing Arsenic Trioxide Treatment
Relapsed acute promyelocytic leukemia in a hemodialysis-dependent patient treated with arsenic trioxide: a case report
A model of tournament incentives with corruption
Speciation of arsenic trioxide metabolites in peripheral blood and bone marrow from an acute promyelocytic leukemia patient
A drug from poison: how the therapeutic effect of arsenic trioxide on acute promyelocytic leukemia was discovered
PML-RARA mutations confer varying arsenic trioxide resistance